Indivior PLC revenue breakdown overview

Indivior PLC revenue for the last year amounted to 1.09 B USD, the most of which — 1.12 B USD — came from its highest performing source at the moment, Buprenorphine-based Prescription Drugs, the year earlier bringing 884.63 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Indivior PLC 933.97 M USD, and the year before that — 717.72 M USD.